Jodi Devlin

Insider Reports History

Location: C/O Trisalus Life Sciences, Inc., 6272 W. 91 St Avenue, Westminster, CO
Signature: /s/ Mary Szela, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jodi Devlin:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
TriSalus Life Sciences, Inc.	Chief of Clinical Operations	Common Stock	52.8K	$273K	$5.18	May 19, 2025	Direct
TriSalus Life Sciences, Inc.	Chief of Clinical Operations	Employee Stock Option (right to buy)	63.8K			Jan 27, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Jodi Devlin

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
TLSI	TriSalus Life Sciences, Inc.	May 19, 2025	2	$100K	4	May 21, 2025	Chief of Clinical Operations
TLSI	TriSalus Life Sciences, Inc.	Feb 18, 2025	1	$0	4	Feb 19, 2025	Chief of Clinical Operations
TLSI	TriSalus Life Sciences, Inc.	Jan 27, 2025	2	$0	4	Jan 29, 2025	Chief of COMMERC. OPERATIONS
TLSI	TriSalus Life Sciences, Inc.	Feb 12, 2024	2	$0	4	Feb 14, 2024	PRESIDENT, COMMERC. OPERATIONS
TLSI	TriSalus Life Sciences, Inc.	Aug 30, 2023	1	$0	4	Aug 31, 2023	President, Therapeutics
TLSI	TriSalus Life Sciences, Inc.	Aug 28, 2023	0	$0	3	Aug 31, 2023	President, Therapeutics